Dcgi Rsquo

Rediff.com » News » Dcgi Rsquo

News for Dcgi Rsquo

News
Business

India will wait for DCGI nod to restart Oxford vaccine trial

The global trials were halted after a study participant suffered a ‘potentially unexplained illness', reports Sohini Das. IMAGE: Serum Institute of India is the Indian partner of AstraZeneca......

SIIto test Novavax's Omicron-specific vaccine

The Drugs Controller General of India has approved the manufacture of this Sars-CoV-2 spike protein recombinant nano-particle vaccine for ‘examination, test, and analysis’,......

Novovax Covid vaccine likely to get nod in India ahead of US

Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending......

India probes four cough syrups after 66 Gambian children's deaths

India's drug regulator has initiated a probe and sought further details from the WHO after the global health body issued an alert that cough syrups manufactured by an Indian firm could potentially......

Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

So far, no other vaccine has been approved globally for children below 12 years.Sohini Das reports. IMAGE: A beneficiary receives a dose of the Covid-19 vaccine at a vaccination centre in......

Pharma cos okay with QR codes to combat counterfeit drugs

As the Drugs Controller General of India (DCGI) is set to crack down on companies to ensure compliance with printing QR codes on top-selling brands to curb counterfeiting, top pharma companies say......

Regulatory woes torpedo PE/VC deals in e-pharma sector

With regulatory uncertainties clouding the future of online pharmacies, deals in the space are showing signs of slowdown, as also fresh investment from private-equity (PE) firms and venture......

What is Schedule M and why it's mandatory for all pharma units

With an eye on improving quality assurance in the wake of increased global scrutiny on Indian pharma products, the Centre on Tuesday said that Schedule M of the Drugs and Cosmetics Act, 1940 will......

Glenmark's favipiravir under fire for 'misguided' claims of Covid-19 drug

The Drug Controller General of India has sent a letter to the Glenmark seeking clarifications on pricing as well as claims of therapeutic efficacy. While Glenmark has claimed this drug is effective......

Drug regulator to make routine inspection of Chinese suppliers

The Indian drug regulator is set to conduct routine inspections at the manufacturing facilities of Chinese and other foreign companies supplying active pharmaceutical ingredients to domestic......

Dcgi Rsquo

News for Dcgi Rsquo

India will wait for DCGI nod to restart Oxford vaccine trial

SIIto test Novavax's Omicron-specific vaccine

Novovax Covid vaccine likely to get nod in India ahead of US

India probes four cough syrups after 66 Gambian children's deaths

Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

Pharma cos okay with QR codes to combat counterfeit drugs

Regulatory woes torpedo PE/VC deals in e-pharma sector

What is Schedule M and why it's mandatory for all pharma units

Glenmark's favipiravir under fire for 'misguided' claims of Covid-19 drug

Drug regulator to make routine inspection of Chinese suppliers

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS